Sally C. Pipes
Commentary
Medicare’s Drug Price Controls Could Actually Raise Prices In The Long Run
Four years ago, on August 16, President Biden signed the Inflation Reduction Act into law. Lawmakers promised that letting Medicare set drug prices would save taxpayers more than $100 billion over a decade. New research suggests the IRA may accomplish the opposite in the long run. A study by University ...
Commentary
CMS Undermining Next Generation of Medicines
Some of the biggest advances in medicine don’t come from discovering entirely new drugs. They come from making existing ones easier to take, faster to administer, safer, and more effective. A new proposal from the Centers for Medicare and Medicaid Services could make those improvements far less common. The agency ...
Commentary
Medicare’s Drug-Pricing Proposal Carries A Hidden Cost
The Trump administration says it wants to accelerate medical innovation. Yet one new proposal from the Centers for Medicare and Medicaid Services could do just the opposite. The agency has proposed a seemingly technical expansion of Medicare’s prescription drug price control scheme, which was created by the Inflation Reduction Act ...
Commentary
Before embracing Medicare for All, the U.S should look at Britain
American doctors already know how government payment works. Private insurers pay roughly twice what Medicare does. After inflation, Medicare physician payments have fallen 33% since 2001. Medicare for All would spread that underpayment across the entire healthcare system. Every physician would have to accept whatever Washington chose to pay. Patients ...
Commentary
Medicare’s Physician Pay Cut Will Cost Patients
The Trump administration has released Medicare’s proposed physician payment rule for 2027. Buried in the hundreds of pages of technical regulations is a familiar outcome — another cut in what physicians will be paid to care for seniors. Under the proposal, Medicare’s basic payment rate would fall by as much ...
Commentary
Hospital price transparency is good politics — and good policy
Few issues will shape this November’s midterm elections more than the rising cost of healthcare. Republicans returning home for the August recess can point to meaningful progress on one of the biggest drivers of those costs: hospital prices. In recent weeks, Congress has moved closer to making hospital price transparency ...
Commentary
Medicare Pays Billions For Obesity’s Consequences. Its GLP-1 Bridge Offers A Better Way
Medicare spends billions of dollars each year treating heart disease, diabetes, kidney disease, cancer and other illnesses caused or worsened by obesity. Yet for decades, federal law has barred the program from covering medicines prescribed to treat obesity itself. In other words, Medicare has been willing to pay for the ...
Commentary
Why Are States Taxing Companies for Hiring Poor People?
The Garden State has become the first state to penalize companies for employing Medicaid beneficiaries. Under legislation signed June 30 by Gov. Mikie Sherrill, D-N.J., companies with at least 50 employees will pay an annual fee between $325 and $725 for every worker or dependent of a worker enrolled in ...
Health Care
New PRI Study: California’s Medi-Cal Crisis Leaves Taxpayers Paying for Fraud, Waste, and Runaway Costs
SACRAMENTO – Just weeks after California approved a record state budget of $351.7 billion for fiscal year 2026-27 that scaled back portions of its Medi-Cal expansion because of soaring costs, and as the federal government announced it was pausing $867.5 million in Medicaid payments to California, the Pacific Research Institute ...
Commentary
Don’t Blame Breakthrough Drugs for Costs, Fix Hospital Market
America’s healthcare tab has hit a new record. According to federal data published late last month, national health expenditures climbed to nearly $5.7 trillion in 2025, an increase of 7.3% over the previous year. The report noted that retail prescription drug spending rose 11%, driven in part by increased use ...
Medicare’s Drug Price Controls Could Actually Raise Prices In The Long Run
Four years ago, on August 16, President Biden signed the Inflation Reduction Act into law. Lawmakers promised that letting Medicare set drug prices would save taxpayers more than $100 billion over a decade. New research suggests the IRA may accomplish the opposite in the long run. A study by University ...
CMS Undermining Next Generation of Medicines
Some of the biggest advances in medicine don’t come from discovering entirely new drugs. They come from making existing ones easier to take, faster to administer, safer, and more effective. A new proposal from the Centers for Medicare and Medicaid Services could make those improvements far less common. The agency ...
Medicare’s Drug-Pricing Proposal Carries A Hidden Cost
The Trump administration says it wants to accelerate medical innovation. Yet one new proposal from the Centers for Medicare and Medicaid Services could do just the opposite. The agency has proposed a seemingly technical expansion of Medicare’s prescription drug price control scheme, which was created by the Inflation Reduction Act ...
Before embracing Medicare for All, the U.S should look at Britain
American doctors already know how government payment works. Private insurers pay roughly twice what Medicare does. After inflation, Medicare physician payments have fallen 33% since 2001. Medicare for All would spread that underpayment across the entire healthcare system. Every physician would have to accept whatever Washington chose to pay. Patients ...
Medicare’s Physician Pay Cut Will Cost Patients
The Trump administration has released Medicare’s proposed physician payment rule for 2027. Buried in the hundreds of pages of technical regulations is a familiar outcome — another cut in what physicians will be paid to care for seniors. Under the proposal, Medicare’s basic payment rate would fall by as much ...
Hospital price transparency is good politics — and good policy
Few issues will shape this November’s midterm elections more than the rising cost of healthcare. Republicans returning home for the August recess can point to meaningful progress on one of the biggest drivers of those costs: hospital prices. In recent weeks, Congress has moved closer to making hospital price transparency ...
Medicare Pays Billions For Obesity’s Consequences. Its GLP-1 Bridge Offers A Better Way
Medicare spends billions of dollars each year treating heart disease, diabetes, kidney disease, cancer and other illnesses caused or worsened by obesity. Yet for decades, federal law has barred the program from covering medicines prescribed to treat obesity itself. In other words, Medicare has been willing to pay for the ...
Why Are States Taxing Companies for Hiring Poor People?
The Garden State has become the first state to penalize companies for employing Medicaid beneficiaries. Under legislation signed June 30 by Gov. Mikie Sherrill, D-N.J., companies with at least 50 employees will pay an annual fee between $325 and $725 for every worker or dependent of a worker enrolled in ...
New PRI Study: California’s Medi-Cal Crisis Leaves Taxpayers Paying for Fraud, Waste, and Runaway Costs
SACRAMENTO – Just weeks after California approved a record state budget of $351.7 billion for fiscal year 2026-27 that scaled back portions of its Medi-Cal expansion because of soaring costs, and as the federal government announced it was pausing $867.5 million in Medicaid payments to California, the Pacific Research Institute ...
Don’t Blame Breakthrough Drugs for Costs, Fix Hospital Market
America’s healthcare tab has hit a new record. According to federal data published late last month, national health expenditures climbed to nearly $5.7 trillion in 2025, an increase of 7.3% over the previous year. The report noted that retail prescription drug spending rose 11%, driven in part by increased use ...